Literature DB >> 7512490

White coat hypertension and related phenomena. A clinical approach.

J Ocón-Pujadas1, J Mora-Maciá.   

Abstract

In this paper, several clinical problems associated with the diagnosis of hypertension are discussed. Blood pressure variability and reactivity are factors underlying the difficulties in the diagnosis of hypertension. These phenomena are interrelated and mixed. White coat hypertension (WCH), referring to the phenomenon of a high diastolic pressure at the doctor's office and a normal diurnal diastolic pressure when it is measured by ambulatory monitoring, is the most important clinical problem of diagnosis. Blood pressure variability is described, since it is essential to understand changes in pressure throughout the day, and its phasic and tonic components. Blood pressure differences between activity and rest, usually seen as daytime/night-time differences, allow for blood pressure control in most patients with moderate hypertension. Prevalence of WCH depends on the cut-off point used by the investigators for normal diurnal blood pressure; thus, between 53% and 12% of patients may have WCH. In our studies, a prevalence of 35% has been found. The alert reaction, labile and borderline hypertension and WCH result from a mix of both variability and reactivity, and patients with these conditions are at a higher cardiovascular risk than normotensive controls. Ambulatory blood pressure monitoring, which enables true hypertensives to be distinguished from false hypertensives, is the most useful technique available to date for the diagnosis of hypertension.

Entities:  

Mesh:

Year:  1993        PMID: 7512490     DOI: 10.2165/00003495-199300462-00017

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  26 in total

1.  Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension.

Authors:  P Verdecchia; G Schillaci; F Boldrini; I Zampi; C Porcellati
Journal:  Hypertension       Date:  1992-10       Impact factor: 10.190

2.  Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies.

Authors:  J A Staessen; R H Fagard; P J Lijnen; L Thijs; R Van Hoof; A K Amery
Journal:  Am J Cardiol       Date:  1991-04-01       Impact factor: 2.778

3.  Prospective study of ambulatory monitoring and echocardiography in borderline hypertension.

Authors:  J D Spence; M Bass; H C Robinson; H Cheung; L J Melendez; J M Arnold; S B Manuck
Journal:  Clin Invest Med       Date:  1991-06       Impact factor: 0.825

4.  The clinical significance of diurnal blood pressure variations. Dippers and nondippers.

Authors:  T G Pickering
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

5.  How common is white coat hypertension?

Authors:  T G Pickering; G D James; C Boddie; G A Harshfield; S Blank; J H Laragh
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

6.  Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension.

Authors:  G Parati; G Pomidossi; F Albini; D Malaspina; G Mancia
Journal:  J Hypertens       Date:  1987-02       Impact factor: 4.844

7.  The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents.

Authors:  J Conway; J Johnston; A Coats; V Somers; P Sleight
Journal:  J Hypertens       Date:  1988-02       Impact factor: 4.844

8.  Neural and humoral mechanisms involved in blood pressure variability.

Authors:  J Conway; N Boon; C Davies; J V Jones; P Sleight
Journal:  J Hypertens       Date:  1984-04       Impact factor: 4.844

9.  "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

Authors:  S Julius; A Mejia; K Jones; L Krause; N Schork; C van de Ven; E Johnson; J Petrin; M A Sekkarie; S E Kjeldsen
Journal:  Hypertension       Date:  1990-12       Impact factor: 10.190

10.  [Day-night differences of arterial pressure in "white coat" arterial hypertension].

Authors:  J Mora-Maciá; J Ocón Pujadas; J M Díaz Gómez; G del Río Pérez
Journal:  Rev Clin Esp       Date:  1993-01       Impact factor: 1.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.